132 related articles for article (PubMed ID: 15909868)
21. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting.
Hanlon GW
Lett Appl Microbiol; 2005; 41(5):375-8. PubMed ID: 16238638
[TBL] [Abstract][Full Text] [Related]
22. Acinetobacter species as nosocomial pathogens.
Forster DH; Daschner FD
Eur J Clin Microbiol Infect Dis; 1998 Feb; 17(2):73-7. PubMed ID: 9629969
[No Abstract] [Full Text] [Related]
23. Acinetobacter calcoaceticus infection in and around manipal (Karnataka).
Kulachandra Singh M; Kireeti J; Joseph A; Subbannayya K; Stephen S; Rao KN
Indian J Pathol Microbiol; 1983 Jan; 26(1):7-13. PubMed ID: 6605922
[No Abstract] [Full Text] [Related]
24. Beta-lactamase producing Acinetobacter species in hospitalized patients.
Kansal R; Pandey A; Asthana AK
Indian J Pathol Microbiol; 2009; 52(3):456-7. PubMed ID: 19680002
[No Abstract] [Full Text] [Related]
25. Clinical significance of Acinetobacter species isolated from cerebrospinal fluid.
Chen HP; Lai CH; Chan YJ; Chen TL; Liu CY; Fung CP; Liu CY
Scand J Infect Dis; 2005; 37(9):669-75. PubMed ID: 16126568
[TBL] [Abstract][Full Text] [Related]
26. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
[TBL] [Abstract][Full Text] [Related]
27. OXA (beta)-lactamases in Acinetobacter: the story so far.
Brown S; Amyes S
J Antimicrob Chemother; 2006 Jan; 57(1):1-3. PubMed ID: 16332731
[TBL] [Abstract][Full Text] [Related]
28. Advances in the way of dealing with antibiotic exposure in studies assessing risk factors for drug-resistant pathogens.
Prates CG; Zavascki AP
Diagn Microbiol Infect Dis; 2009 May; 64(1):102; author reply 103. PubMed ID: 19232855
[No Abstract] [Full Text] [Related]
29. [Acinetobacter and infections].
Kechrid A; Ben Redjeb S; Ennaïfer M; Boujnah A
Tunis Med; 1986 Nov; 64(11):951-3. PubMed ID: 3590334
[No Abstract] [Full Text] [Related]
30. Outbreak of Acinetobacter genomic species 3 in a Dutch intensive care unit.
Idzenga D; Schouten MA; van Zanten AR
J Hosp Infect; 2006 Aug; 63(4):485-7. PubMed ID: 16815591
[No Abstract] [Full Text] [Related]
31. Acinetobacter spp. and time-kill studies.
Lopardo HA
J Antimicrob Chemother; 2008 Feb; 61(2):464; author reply 464-6. PubMed ID: 18033781
[No Abstract] [Full Text] [Related]
32. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of the epidemiological situation and the resistance phenotype of pathogens isolated from patients in the intensive care unite of the Lodz Medical University Hospital No.1 in 2002-2006].
Bartoszko-Tyczkowska A; Gaszyński W; Tyczkowska-Sieroń E
Med Dosw Mikrobiol; 2008; 60(3):223-30. PubMed ID: 19143176
[TBL] [Abstract][Full Text] [Related]
34. Infection due to Mima-Herellea.
Suwanraks C; Jayanetra P; Prachaktham R; Tejavej A
J Med Assoc Thai; 1971 Nov; 54(11):849-57. PubMed ID: 5128925
[No Abstract] [Full Text] [Related]
35. Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis.
Cetin ES; Durmaz R; Tetik T; Otlu B; Kaya S; Calişkan A
Am J Infect Control; 2009 Feb; 37(1):56-64. PubMed ID: 18834735
[TBL] [Abstract][Full Text] [Related]
36. Alert surveillance of intensive care unit-acquired Acinetobacter infections in a Sicilian hospital.
Agodi A; Zarrilli R; Barchitta M; Anzaldi A; Di Popolo A; Mattaliano A; Ghiraldi E; Travali S
Clin Microbiol Infect; 2006 Mar; 12(3):241-7. PubMed ID: 16451411
[TBL] [Abstract][Full Text] [Related]
37. Acinetobacter bacteremia in the tropics.
Seifert H
Clin Infect Dis; 1999 Jan; 28(1):31-2. PubMed ID: 10028066
[No Abstract] [Full Text] [Related]
38. Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001.
van den Broek PJ; Arends J; Bernards AT; De Brauwer E; Mascini EM; van der Reijden TJ; Spanjaard L; Thewessen EA; van der Zee A; van Zeijl JH; Dijkshoorn L
Clin Microbiol Infect; 2006 Sep; 12(9):837-43. PubMed ID: 16882288
[TBL] [Abstract][Full Text] [Related]
39. [Epidemic caused by a multiresistant Acinetobacter baumanii infection; MRSA incognito].
van der Spoel I; Scheffer GJ
Ned Tijdschr Geneeskd; 1999 Apr; 143(15):818-9. PubMed ID: 10347649
[No Abstract] [Full Text] [Related]
40. In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea.
Park YK; Choi JY; Song JH; Ko KS
Int J Antimicrob Agents; 2009 Mar; 33(3):289-90. PubMed ID: 19091518
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
